AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 1 filers reported holding AMAG PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $1,016,000 | – | 50,424 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 2,777,392 | $110,346,000 | 5.31% |
| Opaleye Management Inc. | 200,000 | $7,946,000 | 3.91% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 108,423 | $4,308,000 | 1.58% |
| ASHFORD CAPITAL MANAGEMENT INC | 164,325 | $6,529,000 | 1.53% |
| Endurant Capital Management LP | 94,100 | $3,739,000 | 1.25% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 76,600 | $3,043,000 | 1.15% |
| PYRRHO CAPITAL MANAGEMENT, LP | 32,800 | $1,303,000 | 1.13% |
| AlphaOne Investment Services, LLC | 63,226 | $2,511,000 | 1.07% |
| DELPHI MANAGEMENT INC /MA/ | 131,240 | $5,214,000 | 0.82% |
| CAPITAL GROWTH MANAGEMENT LP | 472,000 | $18,753,000 | 0.60% |